Serum VEGF-C is associated with metastatic site in patients with malignant melanoma

References

• Underiner TL, Ruggeri B, Gingrich DE. Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. Curr Med Chem 2004; 11: 731–45
   PubMed Web of Science ®Google Scholar
• Ishii H, Yazawa T, Sato H, Suzuki T, Ikeda M, Hayashi Y, et al. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer 2004; 45: 325–37
   PubMed Web of Science ®Google Scholar
• Isaka N, Padera TP, Hagendoorn J, Fukumura D, Jain RK. Peritumour lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res 2004; 64: 4400–4
   PubMedGoogle Scholar
• Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 2003; 88: 237–44
   PubMed Web of Science ®Google Scholar
• Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 2004; 101: 1364–74
   PubMed Web of Science ®Google Scholar
• Fujimoto J, Toyoki H, Sato E, Sakaguchi H, Tamaya T. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Br J Cancer 2004; 91: 466–9
   PubMed Web of Science ®Google Scholar
• Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, et al. Aberrant expression of vascular endothelial growth factor-C (VEGF-C) is related to grade of cervical intraepithelial neoplasia (CIN) and high-risk Human papillomavirus (HPV), but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol 2006; 59: 40–7
   PubMed Web of Science ®Google Scholar
• Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 2004; 46: 11–9
   PubMed Web of Science ®Google Scholar
• Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Ohta Y, et al. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 2004; 126: 342–6
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Kitayama J, Kazama S, Nagawa H. The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia. Hepatogastroenterology 2004; 59: 1319–22
   Google Scholar
• Price N. Vascular endothelial growth factors C and D in colorectal cancers. Clin Colorectal Cancer 2004; 1: 23–5
   Google Scholar
• Choi WW, Lewis MM, Lawson D, Yin–Goen Q, Birdsong GG, Cotsonis GA, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: Correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 2005; 18: 143–52
   PubMed Web of Science ®Google Scholar
• Tamura M, Ohta Y. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: A possible diagnostic tool for lymph node metastasis. Cancer 2003; 98: 1217–22
   PubMed Web of Science ®Google Scholar
• Tamura M, Oda M, Matsumoto I, Tsunezuka Y, Kawakami K, Ohta Y, et al. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer. Ann Surg Oncol 2004; 11: 928–33
   PubMed Web of Science ®Google Scholar
• Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M, et al. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervival cancer: relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B. Gynecol Oncol 2005; 98: 467–83
   PubMed Web of Science ®Google Scholar
• Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular growth factor (VEGF) and VEGF-C levels as tumour markers in patients with cervical carcinoma. Cancer 2005; 103: 724–30
   PubMed Web of Science ®Google Scholar
• Goydos JS, Gorski DH. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma. Clin Cancer Res 2003; 9: 5962–7
   PubMed Web of Science ®Google Scholar
• Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, et al. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 2003; 98: 789–97
   PubMed Web of Science ®Google Scholar
• Vuoristo MS, Hahka-Kemppinen M, Parvinen LM, Pyrhönen S, Seppä H, Korpela M, et al. Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma. Melanoma Res 2005; 15: 291–6
   PubMed Web of Science ®Google Scholar
• Hendrix MJC, Seftor EA, Hess AR, Seftor REB. Vascular mimicry and tumour-cell plasticity. Lessons from melanoma. Nature Rev Cancer 2003; 3: 411–21
   PubMed Web of Science ®Google Scholar
• Zhang X, Yamashita M, Uetsuki H, Kakehi Y. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. Int J Urol 2002; 9: 509–14
   PubMed Web of Science ®Google Scholar
• Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obesity 2005; 29: 1308–14
   PubMed Web of Science ®Google Scholar
• Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635–48
   PubMed Web of Science ®Google Scholar
• Lev DC, Ruiz M, Mills L, McGary EC, Price JE, Bar-Eli M. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: A possible escape mechanism from chemotherapy. Mol Cancer Ther 2003; 8: 753–63
   Google Scholar
• Gogas H, Ionnovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 2006; 354: 709–18
   PubMed Web of Science ®Google Scholar